Spectranetics to Hold 2015 Fourth Quarter Financial Results Conference Call on February 25, 2016
February 09 2016 - 4:08PM
The Spectranetics Corporation (Nasdaq:SPNC) today announced that
the Company will release 2015 fourth quarter financial results
after market close on Thursday, February 25, 2016. Company
management will host an investment-community conference call
beginning at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) on
Thursday, February 25 to discuss those results and to answer
questions.
Individuals interested in listening to the conference call may
do so by dialing (877) 561-2747 for domestic callers, or (973)
409-9689 for international callers (Conference ID: 39913305), or
from the webcast on the investor relations section of the Company’s
website at: www.spectranetics.com. The webcast will be available on
the Company’s website for 14 days following the completion of the
call.
About Spectranetics
Spectranetics develops, manufactures, markets
and distributes medical devices used in minimally invasive
procedures within the cardiovascular system. The Company’s products
are sold in over 65 countries and are used to treat arterial
blockages in the heart and legs and in the removal of pacemaker and
defibrillator leads.
The Company’s Vascular Intervention (VI) products include a
range of laser catheters for ablation of blockages in arteries
above and below the knee, the AngioSculpt® scoring balloon used in
both peripheral and coronary procedures and Stellarex™ drug-coated
balloon peripheral angioplasty platform, which received European CE
mark approval in December 2014. The Company also markets support
catheters to facilitate crossing of peripheral and coronary
arterial blockages, and retrograde access and guidewire retrieval
devices used in the treatment of peripheral arterial blockages,
including chronic total occlusions. The Company markets aspiration
and cardiac laser catheters to treat blockages in the heart.
The Lead Management product line includes excimer laser sheaths,
dilator sheaths, mechanical sheaths and accessories for the removal
of pacemaker and defibrillator cardiac leads.
For more information, visit www.spectranetics.com.
Investor Relations Contacts
Zach Stassen, Sr. Director of Finance
investor.relations@spnc.com
(719) 447-2292
Jamar Ismail
investor.relations@spnc.com
(415) 513-1282
The Spectranetics Corp. (MM) (NASDAQ:SPNC)
Historical Stock Chart
From Aug 2024 to Sep 2024
The Spectranetics Corp. (MM) (NASDAQ:SPNC)
Historical Stock Chart
From Sep 2023 to Sep 2024